Muneeb Ahmed, MD FSIR

Chief, Division of Interventional Radiology
Beth Israel Deaconess Medical Center/Harvard

Presentation(s):

• Evaluating Percutaneous Transhepatic Biliary Drainage (PTBD) factors associated with better outcomes in the treatment of Post-Surgical Benign Biliary Strictures

  Sunday, March 5, 2023
  3:09 PM – 3:18 PM

  Disclosure(s): Agile Devices, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Replimune, Inc.: Consultant (Ongoing); RevOps Health, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing)

• To determine the relationship of tumor absorbed dose with microsphere distribution/mL using PET/CT derived tumor to normal ratio (T:N) in HCC patients treated with 90Y radiation segmentectomy.

  Monday, March 6, 2023
  12:00 PM – 1:00 PM

  Disclosure(s): Agile Devices, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Replimune, Inc.: Consultant (Ongoing); RevOps Health, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing)

• Hand Motion Analysis of Different Segments of a Procedure: Is One Segment Enough?

  Monday, March 6, 2023
  12:00 PM – 1:00 PM

  Disclosure(s): Agile Devices, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Replimune, Inc.: Consultant (Ongoing); RevOps Health, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing)

• Ablation 2

  Monday, March 6, 2023
  3:00 PM – 4:30 PM

  Disclosure(s): Agile Devices, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Replimune, Inc.: Consultant (Ongoing); RevOps Health, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing)

• Achieving prescribed tumor absorbed dose in radiation segmentectomy with resin microspheres for HCC: Quantitative PET/CT analysis

  Monday, March 6, 2023
  3:54 PM – 4:03 PM

  Disclosure(s): Agile Devices, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Replimune, Inc.: Consultant (Ongoing); RevOps Health, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing)

• Histopathological Analysis After Transarterial Radioembolization with Yttrium-90 Resin Microspheres

  Monday, March 6, 2023
  4:03 PM – 4:12 PM

  Disclosure(s): Agile Devices, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Replimune, Inc.: Consultant (Ongoing); RevOps Health, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing)

• Alternative Access Sites: Transvisceral Arterial Interventions

  Monday, March 6, 2023
  5:10 PM – 5:15 PM

  Disclosure(s): Agile Devices, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Replimune, Inc.: Consultant (Ongoing); RevOps Health, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing)

• Safety and efficacy of CT-guided cryoablation for recurrent prostate cancer

  Tuesday, March 7, 2023
  3:18 PM – 3:27 PM

  Disclosure(s): Agile Devices, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Replimune, Inc.: Consultant (Ongoing); RevOps Health, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing)

• Endovascular Management of Cirrhotic and Non-Cirrhotic Chronic Portomesenteric Thrombosis

  Wednesday, March 8, 2023
  9:15 AM – 9:30 AM

  Disclosure(s): Agile Devices, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Replimune, Inc.: Consultant (Ongoing); RevOps Health, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing)

• Advanced IR Splenic and Hepatic Vascular Interventions in Peri-Transplant Patients

  Wednesday, March 8, 2023
  1:00 PM – 2:30 PM

  Disclosure(s): Agile Devices, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Replimune, Inc.: Consultant (Ongoing); RevOps Health, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing)

• Transplant Hepatic and Splenic Arterial Interventions in the Post-Transplant Setting

  Wednesday, March 8, 2023
  1:15 PM – 1:30 PM

  Disclosure(s): Agile Devices, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Replimune, Inc.: Consultant (Ongoing); RevOps Health, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing)

• Evaluating HCC Patient Experiences to Identify Factors Associated with Underutilization of HCC Treatment in the US: A SEER-CAHPS Analysis

  Wednesday, March 8, 2023
  3:09 PM – 3:18 PM

  Disclosure(s): Agile Devices, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing); Replimune, Inc.: Consultant (Ongoing); RevOps Health, Inc.: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing)